Efficacy and Safety of Topical 0.05% Cyclosporine Eye Drops in the Treatment of Dry Eye Syndrome: A Systematic Review and Meta-analysis

Ocular Surface

Volumn 13, Issue 3, 2015, Pages 213-225

  Wan, Kelvin H ^a,c   Chen, Li Jia ^b,c   Young, Alvin L ^b,c  

^a TUEN MUN HOSPITAL   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

cornea; cyclosporine; dry eye syndrome; keratoconjunctivitis sicca; meta analysis; ocular surface; systematic review

Indexed keywords

ARTIFICIAL TEAR; CYCLOSPORIN A; EYE DROPS; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT;

ARTICLE; CELL DENSITY; CORNEAL FLUORESCEIN STAINING; DRUG EFFICACY; DRUG SAFETY; DRY EYE; EYE BURNING; EYE PAIN; GOBLET CELL; GOBLET CELL DENSITY; HUMAN; INTRAOCULAR FOREIGN BODY; META ANALYSIS; OCULAR FOREIGN BODY SENSATION; OCULAR SURFACE DISEASE; OCULAR SURFACE DISEASE INDEX SCORE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SCHIRMER TEST; STAINING; STINGING; SYSTEMATIC REVIEW; TEAR FILM; TEAR FILM BREAKUP TIME; TREATMENT OUTCOME; VISUAL SYSTEM PARAMETERS; DOSE RESPONSE; DRY EYE SYNDROMES;

CYCLOSPORINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRY EYE SYNDROMES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; OPHTHALMIC SOLUTIONS; TREATMENT OUTCOME;

EID: 84943349257     PISSN: 15420124     EISSN: 19375913     Source Type: Journal    
DOI: 10.1016/j.jtos.2014.12.006     Document Type: Review

References (78)

1. The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007) Ocul Surf 5 2007 75 92
2. T. Hikichi, A. Yoshida, Y. Fukui, and et al. Prevalence of dry eye in Japanese eye centers Graefes Arch Clin Exp Ophthalmol 233 1995 555 558
3. M.J. Doughty, D. Fonn, D. Richter, and et al. A patient questionnaire approach to estimating the prevalence of dry eye symptoms in patients presenting to optometric practices across Canada Optom Vis Sci 74 1997 624 631
4. K.B. Bjerrum Keratoconjunctivitis sicca and primary Sjogren's syndrome in a Danish population aged 30-60 years Acta Ophthalmol Scand 75 1997 281 286
5. O.D. Schein, B. Munoz, J.M. Tielsch, and et al. Prevalence of dry eye among the elderly Am J Ophthalmol 124 1997 723 728
6. I.A. Mackie, and D.V. Seal Diagnostic implications of tear protein profiles Br J Ophthalmol 68 1984 321 324
7. D.V. Seal The effect of ageing and disease on tear constituents Trans Ophthalmol Soc U K 104 Pt 4 1985 355 362
8. S. Narayanan, R.L. Redfern, W.L. Miller, and et al. Dry eye disease and microbial keratitis: is there a connection? Ocul Surf 11 2013 75 92
9. I.U. Scott, H.W. Flynn Jr., W. Feuer, and et al. Endophthalmitis associated with microbial keratitis Ophthalmology 103 1996 1864 1870
10. W. Stevenson, S.K. Chauhan, and R. Dana Dry eye disease: an immune-mediated ocular surface disorder Arch Ophthalmol 130 2012 90 100
11. C. Baudouin, P. Aragona, E.M. Messmer, and et al. Role of hyperosmolarity in the pathogenesis and management of dry eye disease: proceedings of the OCEAN group meeting Ocul Surf 11 2013 246 258
12. L. Luo, D.Q. Li, A. Doshi, and et al. Experimental dry eye stimulates production of inflammatory cytokines and MMP-9 and activates MAPK signaling pathways on the ocular surface Invest Ophthalmol Vis Sci 45 2004 4293 4301
13. L. Luo, D.Q. Li, R.M. Corrales, and S.C. Pflugfelder Hyperosmolar saline is a proinflammatory stress on the mouse ocular surface Eye Contact Lens 31 2005 186 193
14. J.Y. Niederkorn, M.E. Stern, S.C. Pflugfelder, and et al. Desiccating stress induces T cell-mediated Sjogren's Syndrome-like lacrimal keratoconjunctivitis J Immunol 176 2006 3950 3957
15. Y. Hori, S. Spurr-Michaud, C.L. Russo, and et al. Differential regulation of membrane-associated mucins in the human ocular surface epithelium Invest Ophthalmol Vis Sci 45 2004 114 122
16. H.D. Perry, S. Doshi, E.D. Donnenfeld, and et al. Double-masked randomized controlled study evaluating topical 0.05% cyclosporine A in the treatment of meibomian gland dysfunction (posterior blepharitis) Invest Ophthalmol Vis Sci 44 2003 E-Abstract 1395
17. J.E. Jumblatt, and M.M. Jumblatt Regulation of ocular mucin secretion by P2Y2 nucleotide receptors in rabbit and human conjunctiva Exp Eye Res 67 1998 341 346
18. J. Liu FK506 and cyclosporin, molecular probes for studying intracellular signal transduction Immunol Today 14 1993 290 295
19. R.B. Nussenblatt, and A.G. Palestine Cyclosporine: immunology, pharmacology and therapeutic uses Surv Ophthalmol 31 1986 159 169
20. W.J. Power, P. Mullaney, M. Farrell, and L.M. Collum Effect of topical cyclosporin A on conjunctival T cells in patients with secondary Sjogren's syndrome Cornea 12 1993 507 511
21. A.M. el-Asrar, K.F. Tabbara, K. Geboes, and et al. An immunohistochemical study of topical cyclosporine in vernal keratoconjunctivitis Am J Ophthalmol 121 1996 156 161
22. Chapter 6.4.11: Search filters, in: Higgins JPT, Deeks JJ, Altman DG (eds). Cochrane Handbook of Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]: The Cochrane Collaboration, 2011, available from www.cochrane-handbook.org; 2011, Accessed April 21, 2014.
23. M.A. Lemp Report of the National Eye Institute/Industry workshop on Clinical Trials in Dry Eyes CLAO J 21 1995 221 232
24. M.E. Johnson, and P.J. Murphy Measurement of ocular surface irritation on a linear interval scale with the ocular comfort index Invest Ophthalmol Vis Sci 48 2007 4451 4458
25. R.M. Schiffman, M.D. Christianson, G. Jacobsen, and et al. Reliability and validity of the Ocular Surface Disease Index Arch Ophthalmol 118 2000 615 621
26. G.N. Foulks Challenges and pitfalls in clinical trials of treatments for dry eye Ocul Surf 1 2003 20 30
27. Chapter 9.4.5.2: Meta-analysis of change scores, in: Higgins JPT, Deeks JJ, Altman DG (eds). Cochrane Handbook of Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]: The Cochrane Collaboration, 2011, available from www.cochrane-handbook.org; 2011, Accessed April 21, 2014.
28. Chapter 8: Assessing risk of bias in included studies, in: Higgins JPT, Altman DG, Sterne JAC (eds). Cochrane Handbook of Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]: The Cochrane Collaboration, 2011, available from www.cochrane-handbook.org; 2011, Accessed April 21, 2014.
29. Chapter 9: Analysing data and undertaking meta-analyses, in Deeks JJ, Higgins JPT, Altman DG (eds). Cochrane Handbook of Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]: The Cochrane Collaboration, 2011, available from www.cochrane-handbook.org; 2011, Accessed April 21, 2014.
30. M. Chen, L. Gong, X. Sun, and et al. A comparison of cyclosporine 0.05% ophthalmic emulsion versus vehicle in chinese patients with moderate to severe dry eye disease: An eight-week, multicenter, randomized, double-blind, parallel-group trial J Ocul Pharmacol Ther 26 2010 361 366
31. M. Guzey, S.K. Karaman, A. Satici, and et al. Efficacy of topical cyclosporine A in the treatment of severe trachomatous dry eye Clin Experiment Ophthalmol 37 2009 541 549
32. H.D. Perry, S. Doshi-Carnevale, E.D. Donnenfeld, and et al. Efficacy of commercially available topical cyclosporine A 0.05% in the treatment of meibomian gland dysfunction Cornea 25 2006 171 175
33. P. Prabhasawat, N. Tesavibul, and W. Mahawong A randomized double-masked study of 0.05% cyclosporine ophthalmic emulsion in the treatment of meibomian gland dysfunction Cornea 31 2012 1386 1393
34. S.N. Rao Topical cyclosporine 0.05% for the prevention of dry eye disease progression J Ocul Pharmacol Ther 26 2010 157 163
35. G.M. Salib, M.B. McDonald, and M. Smolek Safety and efficacy of cyclosporine 0.05% drops versus unpreserved artificial tears in dry-eye patients having laser in situ keratomileusis J Cataract Refract Surg 32 2006 772 778
36. K. Sall, O.D. Stevenson, T.K. Mundorf, and B.L. Reis Two multicenter randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease Ophthalmology 107 2000 631 639
37. C.M. Willen, G. McGwin, B. Liu, and et al. Efficacy of cyclosporine 0.05% ophthalmic emulsion in contact lens wearers with dry eyes Eye Contact Lens 34 2008 43 45
38. U.E. Altiparmak, D.E. Acar, P.A. Ozer, and et al. Topical cyclosporine A for the dry eye findings of thyroid orbitopathy patients Eye 24 2010 1044 1050
39. E. Demiryay, V. Yaylal, E.N. Cetin, and C. Yldrm Effects of topical cyclosporine A plus artificial tears versus artificial tears treatment on conjunctival goblet cell density in dysfunctional tear syndrome Eye Contact Lens 37 2011 312 315
40. M.A. Jackson, K. Burrell, I.B. Gaddie, and S.D. Richardson Efficacy of a new prescription-only medical food supplement in alleviating signs and symptoms of dry eye, with or without concomitant cyclosporine A Clin Ophthalmol 5 2011 1201 1206
41. E.C. Kim, J.S. Choi, and C.K. Joo A comparison of vitamin A and cyclosporine A 0.05% eye drops for treatment of dry eye syndrome Am J Ophthalmol 147 2009 206 213.e3
42. J.M. Albietz, and A.S. Bruce The conjunctival epithelium in dry eye subtypes: effect of preserved and non-preserved topical treatments Curr Eye Res 22 2001 8 18
43. S.C. Pflugfelder, C.S. De Paiva, A.L. Villarreal, and M.E. Stern Effects of sequential artificial tear and cyclosporine emulsion therapy on conjunctival goblet cell density and transforming growth factor-beta2 production Cornea 27 2008 64 69
44. M.E. Stern, and S.C. Pflugfelder Inflammation in dry eye Ocul Surf 2 2004 124 130
45. M.O. Li, Y.Y. Wan, and R.A. Flavell T cell-produced transforming growth factor-beta1 controls T cell tolerance and regulates Th1- and Th17-cell differentiation Immunity 26 2007 579 591
46. J.W. Moon, H.J. Lee, K.C. Shin, and et al. Short term effects of topical cyclosporine and viscoelastic on the ocular surfaces in patients with dry eye Korean J Ophthalmol 21 2007 189 194
47. M.E. Stern, R.W. Beuerman, R.I. Fox, and et al. The pathology of dry eye: the interaction between the ocular surface and lacrimal glands Cornea 17 1998 584 589
48. X.J. Song, D.Q. Li, W. Farley, and et al. Neurturin-deficient mice develop dry eye and keratoconjunctivitis sicca Invest Ophthalmol Vis Sci 44 2003 4223 4229
49. P. Prabhasawat, and S.C. Tseng Frequent association of delayed tear clearance in ocular irritation Br J Ophthalmol 82 1998 666 675
50. K.K. Nichols, J.J. Nichols, and G. Lynn Mitchell The relation between tear film tests in patients with dry eye disease Ophthalmic Physiol Opt 23 2003 553 560
51. M. Alves, P.S. Reinach, J.S. Paula, and et al. Comparison of diagnostic tests in distinct well-defined conditions related to dry eye disease PLoS ONE 9 2014 e97921
52. B.D. Sullivan, L.A. Crews, E.M. Messmer, and et al. Correlations between commonly used objective signs and symptoms for the diagnosis of dry eye disease: clinical implications Acta Ophthalmol 92 2014 161 166
53. E.M. Messmer, M. Bulgen, and A. Kampik Hyperosmolarity of the tear film in dry eye syndrome Dev Ophthalmol 45 2010 129 138
54. K.L. Miller, J.G. Walt, D.R. Mink, and et al. Minimal clinically important difference for the ocular surface disease index Arch Ophthalmol 128 2010 94 101
55. O.D. Schein, J.M. Tielsch, B. Munoz, and et al. Relation between signs and symptoms of dry eye in the elderly. A population-based perspective Ophthalmology 104 1997 1395 1401
56. C.G. Begley, R.L. Chalmers, L. Abetz, and et al. The relationship between habitual patient-reported symptoms and clinical signs among patients with dry eye of varying severity Invest Ophthalmol Vis Sci 44 2003 4753 4761
57. K.K. Nichols, J.J. Nichols, and G.L. Mitchell The lack of association between signs and symptoms in patients with dry eye disease Cornea 23 2004 762 770
58. M.A. Lemp, L.A. Crews, A.J. Bron, and et al. Distribution of aqueous-deficient and evaporative dry eye in a clinic-based patient cohort: a retrospective study Cornea 31 2012 472 478
59. M.A. Lemp Advances in understanding and managing dry eye disease Am J Ophthalmol 146 2008 350 356.e1
60. P. Rosenthal, and D. Borsook The corneal pain system. Part I: the missing piece of the dry eye puzzle Ocul Surf 10 2012 2 14
61. F.A. Adatia, A. Michaeli-Cohen, J. Naor, and et al. Correlation between corneal sensitivity, subjective dry eye symptoms and corneal staining in Sjogren's syndrome Can J Ophthalmol 39 2004 767 771
62. L.D. Barber, S.C. Pflugfelder, J. Tauber, and G.N. Foulks Phase III safety evaluation of cyclosporine 0.1% ophthalmic emulsion administered twice daily to dry eye disease patients for up to 3 years Ophthalmology 112 2005 1790 1794
63. D. Stevenson, J. Tauber, and B.L. Reis Efficacy and safety of cyclosporin A ophthalmic emulsion in the treatment of moderate-to-servere dry eye disease: A dose-ranging, randomized trial Ophthalmology 107 2000 967 974
64. K.H. Wan, L.J. Chen, S.S. Rong, and et al. Topical cyclosporine in the treatment of allergic conjunctivitis: a meta-analysis Ophthalmology 120 2013 2197 2203
65. S.C. Pflugfelder, K.R. Wilhelmus, M.S. Osato, and et al. The autoimmune nature of aqueous tear deficiency Ophthalmology 93 1986 1513 1517
66. B.E. Damato, D. Allan, S.B. Murray, and W.R. Lee Senile atrophy of the human lacrimal gland: the contribution of chronic inflammatory disease Br J Ophthalmol 68 1984 674 680
67. T.A. Skwor, B. Atik, R.P. Kandel, and et al. Role of secreted conjunctival mucosal cytokine and chemokine proteins in different stages of trachomatous disease PLoS Negl Trop Dis 2 2008 e264
68. P.J. Driver, and M.A. Lemp Meibomian gland dysfunction Surv Ophthalmol 40 1996 343 367
69. A.J. Bron, N. Yokoi, E. Gafney, and J.M. Tiffany Predicted phenotypes of dry eye: proposed consequences of its natural history Ocul Surf 7 2009 78 92
70. R.L. Chalmers, and C.G. Begley Dryness symptoms among an unselected clinical population with and without contact lens wear Cont Lens Anterior Eye 29 2006 25 30
71. S.E. Wilson, and R.D. Stulting Agreement of physician treatment practices with the international task force guidelines for diagnosis and treatment of dry eye disease Cornea 26 2007 284 289
72. Research in dry eye: report of the Research Subcommittee of the International Dry Eye WorkShop (2007) Ocul Surf 5 2007 179 193
73. K. Gunduz, and O. Ozdemir Topical cyclosporin treatment of keratoconjunctivitis sicca in secondary Sjogren's syndrome Acta Ophthalmol (Copenh) 72 1994 438 442
74. J. Lexchin, L.A. Bero, B. Djulbegovic, and O. Clark Pharmaceutical industry sponsorship and research outcome and quality: systematic review BMJ 326 2003 1167 1170
75. J.E. Bekelman, Y. Li, and C.P. Gross Scope and impact of financial conflicts of interest in biomedical research: a systematic review JAMA 289 2003 454 465
76. L. Bero Industry sponsorship and research outcome: a Cochrane review JAMA Intern Med 173 2013 580 581
77. M. Sacchetti, F. Mantelli, A. Lambiase, and et al. Systematic review of randomised clinical trials on topical ciclosporin A for the treatment of dry eye disease Br J Ophthalmol 98 2014 1016 1022
78. X.Q. Zhou, and R.L. Wei Topical cyclosporine A in the treatment of dry eye: a systematic review and meta-analysis Cornea 33 2014 760 767